Latest Equities News

Visionflex Group Limited reported a mixed quarter with a modest cash burn but strengthened its balance sheet through a significant debt-to-equity conversion and maintained solid funding capacity.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Euroz Hartleys reports a striking 121% jump in net profit for H1 FY2026, driven by booming equity capital markets activity and rising advisory fees. The company also lifts its interim dividend, signalling confidence amid cyclical market conditions.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

American Tungsten & Antimony Ltd is progressing its Nasdaq listing plans with a confidential SEC filing expected in March 2026 and has appointed Deutsche Bank as ADR depositary alongside a new CFO to support growth.

Light & Wonder, Inc. has amended its credit agreement to introduce a new $2.13 billion tranche of term loans due in 2029, replacing prior debt and reducing borrowing costs. The move reflects a strategic refinancing amid its Nasdaq delisting process.

Carnarvon Energy advances its Bedout Sub-basin exploration with a major drilling campaign planned for early 2027, while maintaining a robust financial position and strategic investment in Strike Energy.

Neometals has reported promising gold assay results from its Barrambie drilling program and secured substantial conditional funding for its Vanadium Recovery Project in Finland, while progressing new critical minerals opportunities in the US.

Rox Resources has confirmed the economic viability of its Youanmi Gold Project with a robust feasibility study and commenced underground mining, backed by a $218 million equity raise. The company is on track for first gold production by mid-2027.

Great Northern Minerals has reported promising initial antimony assay results from its newly acquired Catalyst Ridge Project and secured a patent option for advanced rare earth flotation technology from the University of Arizona.

Anteris Technologies Global Corp. has launched a $230 million equity offering alongside an $84 million private placement with Medtronic’s subsidiary, aiming to accelerate clinical trials and scale manufacturing of its innovative DurAVR Transcatheter Heart Valve.

Savana Asset Management’s SVNP ETF delivered a standout 12.9% net return in 2025, outperforming major US equity ETFs despite a volatile year marked by geopolitical tensions and AI-driven market narratives.